These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6189704)

  • 1. [Biochemistry of depression and antidepressants].
    Strolin Benedetti M
    Encephale; 1982; 8(5):545-85. PubMed ID: 6189704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoamine mechanisms in chronic schizophrenia: post-mortem neurochemical findings.
    Crow TJ; Baker HF; Cross AJ; Joseph MH; Lofthouse R; Longden A; Owen F; Riley GJ; Glover V; Killpack WS
    Br J Psychiatry; 1979 Mar; 134():249-56. PubMed ID: 41609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Biochemical aspects of using antidepressants in late middle age and the elderly (review)].
    Burchinskiĭ SG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(4):607-14. PubMed ID: 6134411
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapeutic implications of the biochemical features about depressive illness (author's transl)].
    Lôo H
    Encephale; 1981; 7(4 Suppl):429-40. PubMed ID: 6172268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Significance and value of the study of the metabolites of cerebral mediators (acid metabolites) in the cerebrospinal fluid].
    Casati C; Decina D
    Sist Nerv; 1971; 23(7):42-50. PubMed ID: 5163200
    [No Abstract]   [Full Text] [Related]  

  • 6. Monoamine metabolites in human cerebrospinal fluid: indicators of neuronal activity?
    Scheinin M
    Med Biol; 1985; 63(1):1-17. PubMed ID: 2582215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current biochemical conceptions of mental diseases. II. Role of changes in the biogenic amine system in the pathogenesis of affective disorders].
    Anokhina IP; Gamaleia NB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(6):921-30. PubMed ID: 6158209
    [No Abstract]   [Full Text] [Related]  

  • 8. Naturally-occurring isoquinolines perturb monamine metabolism in the brain: studied by in vivo microdialysis.
    Maruyama W; Nakahara D; Dostert P; Takahashi A; Naoi M
    J Neural Transm Gen Sect; 1993; 94(2):91-102. PubMed ID: 7509158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The current status of biological criteria for classifying the depressive disorders and predicting responses to treatment.
    Schildkraut JJ
    Psychopharmacol Bull; 1974 Jan; 10(1):5-25. PubMed ID: 4590871
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of monoamine oxidase inhibitors in chronic neurodegeneration.
    Riederer P; Müller T
    Expert Opin Drug Metab Toxicol; 2017 Feb; 13(2):233-240. PubMed ID: 27998194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Critical view of biochemical factors in depressive syndromes and the prescription of antidepressants].
    Loo H; Zarifian E
    Ann Med Psychol (Paris); 1982 Feb; 140(2):240-51. PubMed ID: 6180668
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacologic properties of serotonergic agents and antidepressant drugs.
    Fuller RW
    J Clin Psychiatry; 1987 Mar; 48 Suppl():5-11. PubMed ID: 3493240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current biochemical conceptions of mental disorders. I. Biogenic amines in the pathogenesis of schizophrenia].
    Anokhina IP; Gamaleia NB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1979; 79(8):1096-1105. PubMed ID: 384732
    [No Abstract]   [Full Text] [Related]  

  • 14. New contributions from basic science to understanding the effects of monoamine oxidase inhibiting antidepressants.
    Murphy DL; Garrick NA; Aulakh CS; Cohen RM
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):37-43. PubMed ID: 6735994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurotransmitter functions in depression.
    Lapierre YD
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(4-6):639-44. PubMed ID: 6187047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined treatment with MAO-A inhibitor and MAO-B inhibitor increases extracellular noradrenaline levels more than MAO-A inhibitor alone through increases in beta-phenylethylamine.
    Kitaichi Y; Inoue T; Nakagawa S; Boku S; Izumi T; Koyama T
    Eur J Pharmacol; 2010 Jul; 637(1-3):77-82. PubMed ID: 20406628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurochemical applications of liquid chromatography with electrochemical detection.
    Kissinger PT; Bruntlett CS; Shoup RE
    Life Sci; 1981 Feb; 28(5):455-65. PubMed ID: 6163061
    [No Abstract]   [Full Text] [Related]  

  • 18. [Monoamine and monoamine enzyme abnormalities in childhood autism].
    Garnier C; Barthelemy C; Garreau B; Jouve J; Muh JP; Lelord G
    Encephale; 1983; 9(3):201-62. PubMed ID: 6317336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification of serotonergic and noradrenergic neurotransmissions by repeated administration of monoamine oxidase inhibitors: electrophysiological studies in the rat central nervous system.
    Blier P; De Montigny C; Azzaro AJ
    J Pharmacol Exp Ther; 1986 Jun; 237(3):987-94. PubMed ID: 2423685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of various antidepressive agents on brain monoamine oxidase activity].
    Gankina EM; Moskvitina TA; Gorkin VZ; Val'dman AV
    Biull Eksp Biol Med; 1982 Nov; 94(11):29-31. PubMed ID: 7150732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.